ChEMBL: a large-scale bioactivity database for drug discovery
2011 · Nucleic Acids Research · 4,339 citations
https://doi.org/10.1093/nar/gkr777
M
Mark Davies
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
11.2K
Citations
22
h-index
30
i10-index
Mark Davies is an academic researcher. The author has contributed to research in topics: Computational Drug Discovery Methods & Bioinformatics and Genomic Networks & COVID-19 epidemiological studies. The author has an h-index of 22, co-authored 68 publications.
ORCID: 0000-0002-8011-0300Papers by this author
worksThe ChEMBL database in 2017
2016 · Nucleic Acids Research · 2,331 citations
https://doi.org/10.1093/nar/gkw1074
ChEMBL web services: streamlining access to drug discovery data and utilities
2015 · Nucleic Acids Research · 757 citations
https://doi.org/10.1093/nar/gkv352
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · JAMA · 209 citations
https://doi.org/10.1001/jama.2021.18178
UniChem: a unified chemical structure cross-referencing and identifier tracking system
2013 · Journal of Cheminformatics · 178 citations
https://doi.org/10.1186/1758-2946-5-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat